Effects of Crossover Point Exercise on Depression, Anxiety and Stress in Chinese Postmenopausal Women

June 6, 2024 updated by: Beijing Sport University
To analyze the effects of the Crossover Point (COP) Exercise Program on Chinese postmenopausal women.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This is a randomized clinical trial of single-blind with 2 arms (control group and experimental group), in which a pre-treatment-posttest design has been used.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Beijing, China
        • Recruiting
        • School of Sports Medicine and Rehabilitation, Beijing Sport University
        • Contact:
        • Principal Investigator:
          • Peizhen Zhang

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Postmenopausal women without incapacitating chronic disease or contraindications to exercise
  • baseline mental health
  • no severe chronic diseases or exercise contraindications
  • ability to understand the research details and voluntarily sign the informed consent form.

Exclusion Criteria:

  • Women with undetermined menopause;
  • BMI <18.5 kg/m2 or BMI >28 kg/m2
  • uncontrolled hypertension (systolic blood pressure >160 mmHg and/or diastolic blood pressure >110 mmHg)
  • life-threatening illness with a prognosis of <5 years
  • currently receiving estrogen therapy
  • currently taking medication that may affect psychological testing
  • contraindications to exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No Intervention
Active Comparator: crossover point intensity exercise
crossover point intensity exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DASS-21 (Depression Anxiety Stress Scale-21)
Time Frame: At the beginning-at three months.
The scale has 21 questions that cover a wide range of symptoms of depression, anxiety, and stress. Each of the questions was stated in the first person, assertive tone, and required the participants to grade on a 4-point scale their experiences with a score of 0 (did not apply to me at all), 1 (applied to me to some degree or some of the time), 2 (applied to me to a considerable degree or a good part of the time), and 3 (applied to me very much or most of the time). The higher value represents a worse result.
At the beginning-at three months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI )
Time Frame: At the beginning-at three months.
Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2. It is a rough indicator of total body fat.
At the beginning-at three months.
Body Image States Scale (BISS)
Time Frame: At the beginning-at three months.
The BISS contains six items that assess different aspects of body image such as physical appearance, body size and shape, body weight, and attractiveness, as well as concerns about how one looks relative to others. Participants were instructed to complete the questionnaire describing ''How are you feeling right now?'' A higher score represents higher body image satisfaction. The BISS is an internally consistent scale, and construct validity has been confirmed.
At the beginning-at three months.
Body Appreciation Scale-2 (BAS-2)
Time Frame: At the beginning-at three months.
The BAS-2 used in this study is the version revised by Swami et al., it comprises a total of 10 items, scored using a Likert five-point scale, corresponding to the options "Never, Rarely, Sometimes, Often, Always," with each item scored from 1 to 5 points. A higher score indicates a stronger appreciation of one's own body.
At the beginning-at three months.
The Meaning in Life Questionnaire (MLQ)
Time Frame: At the beginning-at three months.
A reliable, valid and practical screening tool for identifying and quantifying Meaning in Life.
At the beginning-at three months.
The Subjective Happiness Scale (SMS)
Time Frame: At the beginning-at three months.
Questionnaire that evaluates the subjective happiness.
At the beginning-at three months.
Body composition
Time Frame: At the beginning-at three months.
Body composition indicators analysis was assessed using DXA. Body compositon indicators include: fat mass,lean body mass,percentage of body fat.
At the beginning-at three months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 20, 2024

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

February 21, 2024

First Submitted That Met QC Criteria

June 6, 2024

First Posted (Actual)

June 10, 2024

Study Record Updates

Last Update Posted (Actual)

June 10, 2024

Last Update Submitted That Met QC Criteria

June 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ECPEDASCPW

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on crossover point intensity exercise

Subscribe